A large Israeli healthcare study examining medical cannabis prescribing patterns autism children found only 1.2% of autistic individuals received prescriptions, but concerning pediatric use patterns suggest need for stricter clinical oversight and guideline adherence.
Fund a medical cannabis trial for children left without NHS access since 2018 – Petitions
✦ New CED Clinical Relevance #86High Clinical Relevance Strong evidence or policy relevance with direct clinical implications. ⚒ Cannabis News | CED Clinic Pediatric MedicineEpilepsyClinical TrialsPolicyAccess Why This MattersSix years after the UK legalized medical cannabis,...
`CBD Autism Trial: Endocannabinoid System Clinical Research`
Clinical Takeaway In this randomized controlled crossover trial, autistic children aged 5 to 12 received weight-based oral CBD oil at 10 mg/kg/day for 12 weeks, with outcomes measured across social relating, anxiety,...
Cannabinoids for Autism: Clinical Evidence-Based Review
Clinical Takeaway Cannabinoid-based treatments, particularly CBD-rich formulations, have shown promising signals for reducing irritability, hyperactivity, and disruptive behaviors in individuals with autism spectrum disorder. Current evidence is limited by small sample sizes...
Man who took daughter to avoid COVID vaccine arguing case at Sask. Court of Appeal
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic PediatricsVaccinesMedical EthicsFamily MedicineLegal Issues Why This MattersThis case represents the ongoing intersection of parental...
Tylenol and Autism: 7 Insights You Need Now
Tylenol has long been the go-to pain reliever during pregnancy, but a new wave of research questions its safety.
This post unpacks the science, the panic, and the human stories behind the headlines on Tylenol and autism.
The truth? It’s complicated, but clarity—and compassion—are possible.